Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

SEB Concept Biotechnology

+ Add to Watchlist

BFGCBIO:LX

117.88 EUR 1.15 0.98%

As of 00:59:30 ET on 01/26/2015.

Snapshot for SEB Concept Biotechnology (BFGCBIO)

Year To Date: +14.53% 3-Month: +23.90% 3-Year: +45.96% 52-Week Range: 66.34 - 117.88
1-Month: +17.53% 1-Year: +62.60% 5-Year: +35.40% Beta vs LUXXX: 0.66

Mutual Fund Chart for BFGCBIO

No chart data available.
  • BFGCBIO:LX 117.88
  • 1M
  • 1Y
Interactive BFGCBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BFGCBIO

SEB Concept Biotechnology is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to achieve long-term capital appreciation. The Fund invests globally in equities and equity-related securities of issuers from the biotechnology sector.

Inception Date: 10-16-2000 Telephone: 352-2-66-82-1 Tel
Managers: ULRIKA BERGMAN
Web Site: www.sebgroup.lu

Fundamentals for BFGCBIO

NAV (on 2015-01-26) 117.88
Assets (M) (on 2015-01-26) 644.28
Fund Leveraged N
Minimum Investment 50.00
Minimum Subsequent Investment -

Dividends for BFGCBIO

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2015-01-15) 0.20
Dividend Yield (ttm) 0.17

Fees & Expenses for BFGCBIO

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.80

Top Fund Holdings for BFGCBIO

Filing Date: 09/30/2014
Name Position Value % of Total
Amgen Inc 345,204 38,384,015 9.417%
Biogen Idec Inc 136,015 35,619,462 8.739%
Gilead Sciences Inc 408,400 34,415,439 8.443%
Celgene Corp 360,598 27,055,897 6.638%
Regeneron Pharmaceuticals Inc 82,276 23,481,425 5.761%
Mylan Inc/PA 528,549 19,033,695 4.670%
Endo International PLC 276,600 14,964,047 3.671%
Salix Pharmaceuticals Ltd 118,092 14,606,112 3.583%
Jazz Pharmaceuticals PLC 111,700 14,197,519 3.483%
Vertex Pharmaceuticals Inc 156,246 13,891,503 3.408%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil